Characterization of AmpC-mediated resistance in clinical Salmonella isolates recovered from humans during the period 1992 to 2003 in England and Wales

Journal of Clinical Microbiology

Volumn 43, Issue 5, 2005, Pages 2261-2265

  Batchelor, M ^a   Hopkins, K L ^b   Threlfall, E J ^b   Clifton Hadley, F A ^a   Stallwood, A D ^a   Davies, R H ^a   Liebana, E ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE AMPC; CEFALEXIN; CEFOTAXIME; CEFOXITIN; CEFRADINE; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; FURAZOLIDONE; GENTAMICIN; IMIPENEM; KANAMYCIN; NALIDIXIC ACID; NEOMYCIN; SPECTINOMYCIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLACMY2 GENE; BLACMY4 GENE; BLADHA1 GENE; GENE TRANSFER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; SALMONELLA; SEROTYPE; TRAVEL; UNITED KINGDOM;

BACTERIAL PROTEINS; BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; ENGLAND; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; PLASMIDS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SALMONELLA; SALMONELLA INFECTIONS; WALES;

SALMONELLA; SALMONELLA ENTERICA;

EID: 18544371821     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.5.2261-2265.2005     Document Type: Article

References (25)

1. Allen, K. J., and C. Poppe. 2002. Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada. Can. J. Vet. Res. 66:137-144.
2. Armand-Lefevre, L., V. Leflon-Guibout, J. Bredin, F. Barguellil, A. Amor, J. M. Pages, and M. H. Nicolas-Chanoine. 2003. Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production. Antimicrob. Agents Chemother. 47:1165-1168.
3. Batchelor, M., F. A. Cliflon-Hadley, A. Stallwood, G. Paiba, R. H. Davies, and E. Liebana. 2005. Detection of multiple cephalosporin resistant Escherichia coli from a cattle fecal sample in Great Britain. Microb. Drug Resist. 11:58-61.
4. Bauernfeind, A., I. Stemplinger, R. Jungwirth, and H. Giamarellou. 1996. Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40:221-224.
5. Carattoli, A., F. Tosini, W. P. Giles, M. E. Rupp, S. H. Hinrichs, F. J. Angulo, T. J. Barrett, and P. D. Fey. 2002. Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob. Agents Chemother. 46:1269-1272.
6. Centers for Diseases Control and Prevention. 2002. Standardized molecular subtyping of foodborne bacterial pathogens by pulsed-field gel electrophoresis. Centers for Diseases Control and Prevention, Atlanta, Ga.
7. Chen, S., S. Zhao, D. G. White, C. M. Schroeder, R. Lu, H. Yang, P. F. McDermott, S. Ayers, and J. Meng. 2004. Characterization of multiple- antimicrobial-resistant Salmonella serovars isolated from retail meats. Appl. Environ. Microbiol. 70:1-7.
8. Chiu, C. H., L. H. Su, C. Chu, J. H. Chia, T. L. Wu, T. Y. Lin, Y. S. Lee, and J. T. Ou. 2004. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 363:1285-1286.
9. Frost, J. A. 1994. Testing for resistance to antimicrobial drugs, p. 73-82. In H. Chart (ed.), Methods in practical bacteriology. CRC Press, Boca Raton, Fla.
10. CMY-2 from multiple Salmonella plasmid backbones. Antimicrob. Agents Chemother. 48:2845-2852.
11. Jenks, P. J., Y. M. Hu, F. Danel, S. Mehtar, and D. M. Livermore. 1995. Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK. J. Antimicrob. Chemother. 35:235-236.
12. Koeck, J. L., G. Arlet, A. Philippen, S. Basmaciogullari, H. V. Thien, Y. Buisson, and J. D. Cavallo. 1997. A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella Senftenberg. FEMS Microbiol. Lett. 152:255-260.
13. Liebana, E., M. Batchelor, F. A. Clifton-Hadley, R. H. Davies, K. L. Hopkins, and E. J. Threlfall. 2004. First report of Salmonella with the DHA-1 AmpC beta-lactamase in the United Kingdom. Antimicrob. Agents Chemother. 48:4492.
14. Liebana, E., M. Batchelor, C. Torres, L. Brinas, L. A. Lagos, B. Abdalhamid, N. D. Hanson, and J. Martinez-Urtaza. 2004. Pediatric infection due to multiresistant Salmonella enterica serotype Infantis in Honduras. J. Clin. Microbiol. 42:4885-4888.
15. Liebana, E., M. Gibbs, C. Clouting, L. Barker, F. A. Clifton-Hadley, E. Pleydell, B. Abdalhamid, N. D. Hanson, L. Martin, C. Poppe, and R. H. Davies. 2004. Characterisation of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom. Microb. Drug Resist. 10:1-9.
16. Miriagou, V., R. Filip, G. Coman, and L. S. Tzouvelekis. 2002. Expanded-spectrum cephalosporin-resistant Salmonella strains in Romania. J. Clin. Microbiol. 40:4334-4336.
17. Navarro, F., E. Perez-Trallero, J. M. Marimon, R. Aliaga, M. Gomariz, and B. Mirelis. 2001. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Eschenchia coli strains isolated in Spain (October 1999-December 2000). J. Antimicrob. Chemother. 48:383-389.
18. NCCLS. 1999. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: approved standard. NCCLS document M31-A. NCCLS, Wayne, Pa.
19. Orman, B. E., S. A. Pineiro, S. Arduino, M. Galas, R. Melano, M. I. Caffer, D. O. Sordelli, and D. Centron. 2002. Evolution of multiresistance in non-typhoid Salmonella serovars from 1984 to 1998 in Argentina. Antimicrob. Agents Chemother. 46:3963-3970.
20. Payne, D. J., N. Woodford, and S. G. Amyes. 1992. Characterization of the plasmid mediated beta-lactamase BIL-1. J. Antimicrob. Chemother. 30:119-127.
21. Perez-Perez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
22. Rankin, S. C., H. Aceto, J. Cassidy, J. Holt, S. Young, B. Love, D. Tewari, D. S. Munro, and C. E. Benson. 2002. Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J. Clin. Microbiol. 40:4679-4684.
23. Stapleton, P. D., K. P. Shannon, and G. L. French. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206-1210.
24. Walker, R. A., N. Saunders, A. J. Lawson, E. A. Lindsay, M. Dassama, L. R. Ward, M. J. Woodward, R. H. Davies, E. Liebana, and E. J. Threlfall. 2001. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. J. Clin. Microbiol. 39:1443-1448.
25. CMY-2 in a Taiwanese university hospital. J. Formos. Med. Assoc. 101:665-668.